盐酸氨溴索结合盐酸丙卡特罗治疗小儿肺炎效果观察

2019-10-21 08:37:18康晓梅
中外女性健康研究 2019年15期

康晓梅

【摘 要】 目的:观察盐酸氨溴索结合盐酸丙卡特罗治疗小儿肺炎的效果。方法:随机选取2016年8月至2018年8月本院小儿肺炎患儿60例,随机分为两组:一组为常规治疗组(30例),一组为在常规治疗基础上使用盐酸氨溴索结合盐酸丙卡特罗治疗的结合治疗组30例,统计分析两组患儿的临床疗效、临床症状消失时间、不良反应发生情况。结果:结合治疗组患儿治疗的总有效率93.3%(28/30)显著高于常规治疗组73.3%(22/30)(P<0.05),咳嗽消失时间显著短于常规治疗组(P<0.05),发热消失时间显著短于常规治疗组(P<0.05),肺部哮鸣音消失时间显著短于常规治疗组(P<0.05),不良反应发生率6.7%(2/30)显著低于常规治疗组23.3%(7/30)(P<0.05)。结论:盐酸氨溴索结合盐酸丙卡特罗治疗小儿肺炎效果好。

【关键词】 盐酸氨溴索;盐酸丙卡特罗;小儿肺炎

Observation of effect of ambroxol hydrochloride combined with procaterol hydrochloride in the treatment of infantile pneumonia

Kang Xiaomei

Jingbian County Traditional Chinese Medicine Hospital, Yulin, Shaanxi 718500

[Abstract] Objective:To observe the effect of ambroxol hydrochloride combined with procaterol hydrochloride in the treatment of infantile pneumonia. Methods: 60 cases of children with pneumonia in our hospital from August 2016 to August 2018 were randomly selected and randomly divided into two groups: a group of conventional treatment group (30 cases), a group of ambroxol hydrochloride combined with procaterol hydrochloride treatment based on conventional treatment group (combined treatment group, 30 cases), the clinical efficacy, clinical symptoms disappearance time, adverse reactions of the two groups of children were statistically analyzed. Results: The total effective rate of the combined treatment group 93.3% (28/30) was significantly higher than the conventional treatment group 73.3% (22/30) (P<0.05). The cough disappearance time, fever disappearance time and lung wheezing disappearance time were significantly shorter than the conventional treatment group (P<0.05). The incidence of adverse reactions 6.7% (2/30) was significantly lower than the conventional treatment group 23.3% (7/30) (P<0.05). Conclusion: Ambroxol hydrochloride combined with procaterol hydrochloride is effective in the treatment of infantile pneumonia.

[Key words]Ambroxol hydrochloride; Procaterol hydrochloride; Pneumonia in children

小兒肺炎多发于婴幼儿时期,在临床较为常见,发热、咳嗽、肺部哮鸣音等是其主要临床症状,由于患儿具有较小的年龄、较差的身体免疫力及抵抗力,因此若发病后如果没有得到及时有效的治疗,那么极易进一步加重患儿病情,严重的情况下还会促进重症肺炎的发生,对患儿生命安全造成威胁,引发婴幼儿死亡[1]。现阶段,抗生素类药物、糖皮质激素是临床治疗小儿肺炎过程中通常采用的药物,但是缺乏令人满意的临床疗效。本研究观察了盐酸氨溴索结合盐酸丙卡特罗治疗小儿肺炎效果。

1 资料与方法

1.1 一般资料

随机选取2016年8月至2018年8月本院小儿肺炎患儿60例,随机分为两组:一组为常规治疗组(30例),一组在常规治疗基础上使用盐酸氨溴索结合盐酸丙卡特罗治疗(结合治疗组,30例)。结合治疗组患儿中男性16例,女性14例,年龄0.25~11岁,平均(5.6±1.4)岁;病程2~14d,平均(7.4±1.6)d。常规治疗组患儿中男性15例,女性15例,年龄1~11岁,平均(6.3±1.5)岁;病程3~14d,平均(7.8±1.8)d。两组患儿的一般资料比较差异均不显著(P>0.05),可比较。

登录APP查看全文